top of page


Age Management of West Michigan

Integrative Medicine

Conventional, Functional, and Anti-Aging Regenerative Medicine located in Grand Rapids, MI.
Dr. Shahnaz Ali            Dr. Piyush Bhatnagar


Sermorelin Peptide Therapy

Sermorelin peptide therapy stimulates an increase in the body’s natural production of Human Growth Hormone by mimicking the effect of GHRH(Growth Hormone Releasing Hormone).   Elevated HGH and circulating IGF-1 levels stimulate the body to repair and rejuvenate itself and slow the signs and symptoms of aging.  Since Sermorelin stimulates the pituitary gland to naturally increase HGH production, this allows for long term usage and benefits with minimal to no side effects associated with traditional Human Growth Hormone therapy.   Most Sermorelin users notice an increase in energy, libido, and better sleep within the fiirst two weeks of use.  Sermorelin therapy can be used in conjunction with BHRT and other anti-aging modalities to provided patients with optimal results.

Why you need to use Sermorelin

As we age, our body’s natural production of human growth hormone (HGH) declines, resulting in a decline in our body’s ability to stimulate tissue repair and regenerate our cells to keep us healthy. This natural decline is responsible for the symptoms of aging that include the loss of muscle mass and bone density, an increase in body fat storage, loss of skin elasticity, thinning of the hair, and poor sleep patterns. At the age of 20, our natural HGH levels are at its peak but suddenly decline consistently after the age of 30. By the age of 40, most individuals’ HGH levels are 40% lower than they were at there peak at age 20 and continue to decline by 14% each decade.

Sermorelin HGH Peptide Therapy Benefits:

Increased Lean Muscle Mass

Increased Energy and Vitality

Enhanced Immune System Function

Reduced Body Fat

Improved Mental Clarity (memory and cognitive function)

Strengthen the Heart and All Organ Systems

Increased Bone Density

Improved Mood

Increase Protein Synthesis

Increased Sexual Performance and Desire

Improved Sleep Quality (by promoting non-REM slow-wave sleep)

Accelerate Healing and Recovery (from activity/exercise/injury)

What Should I Expect With Sermorelin Peptide Therapy?

Sermorelin therapy is most effective when used as a long-term program to prevent the signs and symptoms associated with aging. We recommend a minimum of six months of sermorelin treatment to get regenerative and restorative effect from treatment.. Sermorelin can be used indefinitely with minimal side effects for long-term use.  Results can be seen within the first couple of weeks of treatment. 

Weeks 1-2:  Most patients first notice an improvement in sleep quality and energy throughout the day.  Improved sleep patterns with deeper and more restful sleep. Weeks 4-6:  Changes in body composition with ability to increase lean muscle (hyperplasia), increase metabolism and fat burning, increase bone density,  increased ability to recover from injury or illness along with decreases in joint and muscle pain, fatigue, and depression. 

Weeks 10-12:   Physiological aesthetic changes are noticed with thicker hair and increase hair growth, increased skin elasticity and thickening with decreased cellulite and wrinkles, and nail growth.  Overall improvements in mental focus and cognitive function are also a common treatment result.


Sermorelin peptide therapy can be used combination with BHRT, TRT, HCG, and other peptide treatments.  

Schedule your FREE consultation!
Research and References

1.  Tavares AB, Micmacher E, Biesek S, et al. Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old. Int J Endocrinol. 2013;2013:942030. doi:10.1155/2013/942030.

2.  Wüster C, Härle U, Rehn U, Müller C, Knauf K, Köppler D, Schwabe C, Ziegler R. Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis. Growth Horm IGF Res. 1998 Feb;8 Suppl A:87-94. doi: 10.1016/s1096-6374(98)80016-6. PMID: 10993598.

3.  Olney RC. Regulation of bone mass by growth hormone. Med Pediatr Oncol. 2003 Sep;41(3):228-34. doi: 10.1002/mpo.10342. PMID: 12868124.

4.  Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, Landy H, Eengrand P, Shah S. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996 Mar;81(3):1189-96. doi: 10.1210/jcem.81.3.8772599. PMID: 8772599.

5.  Kanashiro-Takeuchi RM, Takeuchi LM, Rick FG, Dulce R, Treuer AV, Florea V, Rodrigues CO, Paulino EC, Hatzistergos KE, Selem SM, Gonzalez DR, Block NL, Schally AV, Hare JM. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):559-63. doi: 10.1073/pnas.1119203109. Epub 2011 Dec 27. PMID: 22203988; PMCID: PMC3258609.

6.  Khorram O, Yeung M, Vu L, Yen SS. Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women. J Clin Endocrinol Metab. 1997 Nov;82(11):3590-6. doi: 10.1210/jcem.82.11.4363. PMID: 9360512.

7.  Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, Stevens T, Bellantoni MF, Rogers MA, Baumann G, Roth J, Harman SM, Spencer RG. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997 Jan;46(1):89-96. doi: 10.1016/s0026-0495(97)90174-8. PMID: 9005976.

8.  Hong JW, Park JK, Lim CY, Kim SW, Chung YS, Kim SW, Lee EJ. A weekly administered sustained-release growth hormone reduces visceral fat and waist circumference in abdominal obesity. Horm Metab Res. 2011 Dec;43(13):956-61. doi: 10.1055/s-0031-1291246. Epub 2011

Nov 9. PMID: 22072433.

9.  Kim KR, Nam SY, Song YD, Lim SK, Lee HC, Huh KB. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults. Horm Res. 1999;51(2):78-84. doi: 10.1159/000023319. PMID: 10352397.

10.  Dioufa N, Schally AV, Chatzistamou I, et al. Acceleration of wound healing by growth hormone-releasing hormone and its agonists. Proc Natl Acad Sci U S A. 2010;107(43):18611-18615. doi:10.1073/pnas.1013942107.

11.  Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, Vitiello MV. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol. 2012 Nov;69(11):1420-9. doi: 10.1001/archneurol.2012.1970. PMID: 22869065; PMCID: PMC3764914.

12.   High WM Jr, Briones-Galang M, Clark JA, et al. Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J Neurotrauma. 2010;27(9):1565-1575. doi:10.1089/neu.2009.1253.

bottom of page